Irritable Bowel Syndrome Trial, Recruiting (NCT01762579)

Irritable Bowel Syndrome Trial, Recruiting NCT01762579 Sponsor: University of Palermo Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT01762579 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an adult aged between 18 and 65 years old (any gender)
You have symptoms similar to Irritable Bowel Syndrome (IBS), such as digestive discomfort or bowel problems
Your symptoms got better when you stopped eating gluten, and got worse when you started eating gluten again
You have been tested and the results show you do NOT have celiac disease (confirmed by blood tests and a gut tissue sample showing little to no damage)
You have been tested and the results show you do NOT have a wheat allergy (confirmed by a blood test)

Who may not be able to join:

People who have been diagnosed with celiac disease (confirmed by blood tests and a gut tissue sample showing significant damage)
People who have been diagnosed with a wheat allergy (confirmed by a blood test)
People who have Type 1 Diabetes
People who have been diagnosed with Inflammatory Bowel Disease, such as Crohn's disease or ulcerative colitis
People who have an active infection in their digestive system, including a Helicobacter pylori (stomach bacteria) infection
People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01762579

Sponsor: University of Palermo

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

More information: https://clinicaltrials.gov/study/NCT01762579

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an adult aged between 18 and 65 years old (any gender)
You have symptoms similar to Irritable Bowel Syndrome (IBS), such as digestive discomfort or bowel problems
Your symptoms got better when you stopped eating gluten, and got worse when you started eating gluten again
You have been tested and the results show you do NOT have celiac disease (confirmed by blood tests and a gut tissue sample showing little to no damage)
You have been tested and the results show you do NOT have a wheat allergy (confirmed by a blood test)

Who may not be able to join:

People who have been diagnosed with celiac disease (confirmed by blood tests and a gut tissue sample showing significant damage)
People who have been diagnosed with a wheat allergy (confirmed by a blood test)
People who have Type 1 Diabetes
People who have been diagnosed with Inflammatory Bowel Disease, such as Crohn's disease or ulcerative colitis
People who have an active infection in their digestive system, including a Helicobacter pylori (stomach bacteria) infection
People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Palermo

Registry

ClinicalTrials.gov

Start date

1 January 2012

Est. completion

1 January 2016

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Symptoms/signs evaluation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov